黄色网址在线播放

www.22xxs.com 提示:

本信息仅供医学专业人士参考，如果您是医学专业人士，请点击确定后进入。 如果不是，请点击取消。

取消 确定

KTbio Group has always been committed to solving the problem of
clinical drug use for patients, constantly conquering the challenges
of the disease, using high-quality drugs to improve the quality of
life of patients, and working hard for the benefit of human health.

Honors and Awards

KTbio Group is a Chinese bio-pharmaceutical company which is driven by innovation, based on China and oriented in the whole world.

As a Chinese pharmaceutical enterprise, KTbio Group has never forgotten its original will, has attached great importance to and supported the development of China’s health undertaking and has always been committed to benefiting worldwide patients with high-quality drugs and affordable prices.KTbio Group has won high trust and recognition from Chinese Government, doctors and patients through persistence.

  • 2020s

  • 2015s

  • 2010s

  • 2005s

  • 2000s

  • 1995s

  • 1990s

<

  • In January 2018, KTbio Group was honored as the most valuable phar- maceutical company at the 2017 Golden Hong Kong Stocks Awards

    2018-01

  • In August 2016, KTbio Group won the title of “Observing Contracts and Valuing Credit” of Shenyang City in 2015

    2016-08

  • In July 2016, KTbio Group won the award of Best Industrial Enterprise in Chinese Pharmaceutical R&D Production Lines in 2016

    2016-07

  • In March 2016, KTbio Group was honored as the most innovative pharmaceutical enterprise

    2016-03

>
<

  • In October 2015, KTbio Group won the Bayhelix Pharmaceutical Business Achievement Award

    2015-05

  • In July 2015, KTbio Group was honored as the fastest growing company in China’s pharmaceu- tical industry

    2015-07

  • In May 2015, KTbio Group won the Tax Credit A-class Certificate in Shen yang

    2015-05

  • In December 2013, KTbio Group won the “Great Vision - Social Responsi- bility Award” of Vision 2014 “the Reform Drives the Future”

    2013-12

  • In August 2012, the improvement of quality standards of recombinant human erythropoietin was awarded the “Returned Overseas Chinese Contribution Award”

    2012-08

  • In 2011, KTbio Group was honored as the Top 100 Taxpayers in Shenyang

    2011-12

  • In December 2011, KTbio Group was the winner of “Ankang Cup” Competition in Shenyang

    2011-12

  • In October 2011, KTbio Group was conferred with a thank-you letter on the support of 2011 national training activities of the Ministry of Health’s peritoneal dialysis standard operation plan

    2011-10

>
<

  • In January 2010, KTbio Group was honored as the advanced company of statistical work in the pharmaceutical industry in Liaoning Province

    2010-01

  • In January 2010, KTbio Group was honored as the Top 100 Taxpayers in 2009 in Shenyang

    2010-01

  • In December 2009, KTbio Group became the star of China quality manager for pharmaceuticals

    2009-12

  • In July 2009, KTbio Group was conferred with a thank-you letter on the support of 2009 Annual Conference of Chinese Nephrologist Association by Chinese Nephrologist Association

    2009-07

  • In March 2009, KTbio Group was honored as the Star Enterprise in Shenyang

    2009-03

  • In July 2008, KTbio Group was honored as the model enterprise on drug quality and integrity building in the national pharmaceutical industry

    2008-07

  • In May 2008, KTbio Group was awarded with the Certificate on Thanks for Your Contribution to the Sichuan’s Earthquake Disaster Area by Shen Yang Red Cross

    2008-05

  • In 2008, KTbio Group won the Best Cooperation Award

    2008-01

  • In July 2006, KTbio Group was conferred with a thank-you letter on the support of 2006 Annual Conference of Chinese Nephrologist Association by Chinese Nephrologist Association

    2006-07

>
<

  • In 2005, KTbio Group was honored as the National High-tech Industriali- zation Demonstration Project

    2005-12

  • In September 2005, it became the famous-brand product in Shen yang

    2005-09

  • In February 2004, “Pre- paration and production methods for recombinant human thrombopoietin preparations” won the patent certificate for invention

    2004-02

  • In March 2004, “Pre- paration and production methods for recombinant human erythropoietin preparations” won the patent certificate for invention

    2004-03

  • In October 2004, “A production method of the drug for enhancing the in vivo stability of polypeptides and its application” won the patent certificate for invention

    2004-10

  • In April 2003, KTbio Group became the AAA-level unit

    2003-04

  • In December 2002, “A new human thrombopoietin” won the patent certificate for invention

    2002-12

  • In March 2002, KTbio Group was honored as the Top 30 Private Enterprises in Shenyang

    2002-03

  • In September 2001, KTbio Group became the industrialization base of national high-tech research and development program results

    2001-09

>
<

  • In April 1999, KTbio Group became the national high-tech enterprise

    1999-04

  • In 1999, KTbio Group became the national postdoctoral workstation

    1999-05

>
<
>
<
>
m wap